22nd Century Price to Sales Ratio 2011-2024 | XXII
Historical PS ratio values for 22nd Century (XXII) over the last 10 years. The current P/S ratio for 22nd Century as of November 04, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| 22nd Century P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-11-01 |
0.10 |
|
0.01 |
| 2024-06-30 |
0.75 |
$15.45 |
0.05 |
| 2024-03-31 |
1.92 |
$23.54 |
0.08 |
| 2023-12-31 |
2.98 |
$32.05 |
0.09 |
| 2023-09-30 |
15.64 |
$31.06 |
0.50 |
| 2023-06-30 |
91.85 |
$38.86 |
2.36 |
| 2023-03-31 |
184.56 |
$48.78 |
3.78 |
| 2022-12-31 |
220.92 |
$51.53 |
4.29 |
| 2022-09-30 |
222.55 |
$66.75 |
3.33 |
| 2022-06-30 |
511.20 |
$56.13 |
9.11 |
| 2022-03-31 |
556.80 |
$50.01 |
11.13 |
| 2021-12-31 |
741.60 |
$48.03 |
15.44 |
| 2021-09-30 |
710.40 |
$48.43 |
14.67 |
| 2021-06-30 |
1111.20 |
$49.54 |
22.43 |
| 2021-03-31 |
789.60 |
$47.69 |
16.56 |
| 2020-12-31 |
528.00 |
$48.59 |
10.87 |
| 2020-09-30 |
153.79 |
$49.80 |
3.09 |
| 2020-06-30 |
183.46 |
$49.53 |
3.70 |
| 2020-03-31 |
180.00 |
$49.60 |
3.63 |
| 2019-12-31 |
264.00 |
$49.50 |
5.33 |
| 2019-09-30 |
542.40 |
$49.43 |
10.97 |
| 2019-06-30 |
501.60 |
$47.47 |
10.57 |
| 2019-03-31 |
410.40 |
$49.63 |
8.27 |
| 2018-12-31 |
597.60 |
$47.69 |
12.53 |
| 2018-09-30 |
674.40 |
$48.01 |
14.05 |
| 2018-06-30 |
590.40 |
$48.40 |
12.20 |
| 2018-03-31 |
564.00 |
$45.27 |
12.46 |
| 2017-12-31 |
672.00 |
$40.99 |
16.39 |
| 2017-09-30 |
664.80 |
$36.93 |
18.00 |
| 2017-06-30 |
420.00 |
$35.38 |
11.87 |
| 2017-03-31 |
283.20 |
$34.09 |
8.31 |
| 2016-12-31 |
261.60 |
$37.97 |
6.89 |
| 2016-09-30 |
348.00 |
$38.27 |
9.09 |
| 2016-06-30 |
194.90 |
$38.06 |
5.12 |
| 2016-03-31 |
187.92 |
$37.45 |
5.02 |
| 2015-12-31 |
336.00 |
$29.97 |
11.21 |
| 2015-09-30 |
201.60 |
$19.65 |
10.26 |
| 2015-06-30 |
225.60 |
$10.87 |
20.75 |
| 2015-03-31 |
206.40 |
$2.63 |
78.52 |
| 2014-12-31 |
396.00 |
$2.19 |
180.94 |
| 2014-09-30 |
604.80 |
$41.91 |
14.43 |
| 2014-06-30 |
736.80 |
$41.92 |
17.58 |
| 2014-03-31 |
780.00 |
$41.85 |
18.64 |
| 2013-12-31 |
513.60 |
$39.99 |
12.84 |
| 2013-09-30 |
309.60 |
$0.29 |
1067.09 |
| 2013-06-30 |
170.40 |
$0.15 |
1168.91 |
| 2013-03-31 |
211.20 |
$0.15 |
1448.79 |
| 2012-12-31 |
180.00 |
$0.15 |
1234.76 |
| 2012-09-30 |
67.20 |
$0.01 |
0.00 |
| 2012-06-30 |
84.00 |
$5.26 |
15.97 |
| 2012-03-31 |
148.80 |
$7.46 |
19.96 |
| 2011-12-31 |
100.80 |
$9.13 |
11.04 |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.003B |
$0.032B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
